Docebo Inc. (TSE:DCBO – Get Free Report) insider Lauren Anne Tropeano sold 367 shares of the company’s stock in a transaction dated Monday, September 14th. The stock was sold at an average price of C$33.60, for a total value of C$12,331.20. Following the completion of the transaction, the insider directly owned 2,236 shares in the company, valued at approximately C$75,129.60. The trade was a 14.10% decrease in their ownership of the stock.
Docebo Stock Down 0.1%
Shares of DCBO traded down C$0.03 during midday trading on Tuesday, reaching C$34.89. 14,112 shares of the stock were exchanged, compared to its average volume of 103,433. The company has a market cap of C$870.44 million, a price-to-earnings ratio of 30.34 and a beta of 0.28. The company has a quick ratio of 3.25, a current ratio of 0.76 and a debt-to-equity ratio of -30,643.19. Docebo Inc. has a 12-month low of C$19.87 and a 12-month high of C$42.52. The firm has a 50 day simple moving average of C$30.77 and a 200-day simple moving average of C$26.93.
Docebo (TSE:DCBO – Get Free Report) last announced its quarterly earnings results on Friday, August 7th. The company reported C$0.50 EPS for the quarter. Docebo had a return on equity of 114.70% and a net margin of 13.23%.The business had revenue of C$97.54 million during the quarter. Research analysts forecast that Docebo Inc. will post 1.6842684 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Docebo
Docebo Company Profile
Docebo (NASDAQ: DCBO; TSX: DCBO) is the enterprise platform for the AI-era workforce, unifying skills intelligence, learning, and knowledge in one closed loop. Docebo gives organizations the tools to close skills gaps, develop talent, and perform at their best in an AI-driven world.
Recommended Stories
- Five stocks we like better than Docebo
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Docebo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docebo and related companies with MarketBeat.com's FREE daily email newsletter.
